OTC Pharmaceuticals in the Czech Republic


November 1, 2010
42 Pages - SKU: MTLN6571572
License type:
Table of Contents Search inside this report Related Reports
EXECUTIVE SUMMARY
MARKET OVERVIEW
Market definition
Research highlights
Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
LEADING COMPANIES
Johnson & Johnson
GlaxoSmithKline Plc
Zentiva NV
MARKET DISTRIBUTION
MARKET FORECASTS
Market value forecast
MACROECONOMIC INDICATORS
APPENDIX
Methodology
Industry associations
Related Datamonitor research
Disclaimer
ABOUT DATAMONITOR
Premium Reports
Summary Reports
Datamonitor consulting
LIST OF TABLES
Table 1: Czech Republic OTC pharmaceuticals market value: $ million, 2005-09
Table 2: Czech Republic OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 3: Czech Republic OTC pharmaceuticals market segmentation II: % share, by value, 2009
Table 4: Czech Republic OTC pharmaceuticals market share: % share, by value, 2009
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: key financials ($)
Table 7: Johnson & Johnson: key financial ratios
Table 8: GlaxoSmithKline Plc: key facts
Table 9: GlaxoSmithKline Plc: key financials ($)
Table 10: GlaxoSmithKline Plc: key financials (£)
Table 11: GlaxoSmithKline Plc: key financial ratios
Table 12: Zentiva NV: key facts
Table 13: Czech Republic OTC pharmaceuticals market distribution: % share, by value, 2009
Table 14: Czech Republic OTC pharmaceuticals market value forecast: $ million, 2009-14
Table 15: Czech Republic size of population (million), 2005-09
Table 16: Czech Republic gdp (constant 2000 prices, $ billion), 2005-09
Table 17: Czech Republic gdp (current prices, $ billion), 2005-09
Table 18: Czech Republic inflation, 2005-09
Table 19: Czech Republic consumer price index (absolute), 2005-09
Table 20: Czech Republic exchange rate, 2005-09
LIST OF FIGURES
Figure 1: Czech Republic OTC pharmaceuticals market value: $ million, 2005-09
Figure 2: Czech Republic OTC pharmaceuticals market segmentation I:% share, by value, 2009
Figure 3: Czech Republic OTC pharmaceuticals market segmentation II: % share, by value, 2009
Figure 4: Czech Republic OTC pharmaceuticals market share: % share, by value, 2009
Figure 5: Forces driving competition in the OTC pharmaceuticals market in the Czech Republic, 2009
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in the Czech Republic, 2009
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in the Czech Republic, 2009
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the Czech Republic, 2009
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the Czech Republic, 2009
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in the Czech Republic, 2009
Figure 11: Johnson & Johnson: revenues & profitability
Figure 12: Johnson & Johnson: assets & liabilities
Figure 13: GlaxoSmithKline Plc: revenues & profitability
Figure 14: GlaxoSmithKline Plc: assets & liabilities
Figure 15: Czech Republic OTC pharmaceuticals market distribution: % share, by value, 2009
Figure 16: Czech Republic OTC pharmaceuticals market value forecast: $ million, 2009-14
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Over-the-Counter Drugs Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!